Search

Author/Creator Carrillo, Ray

1. 712 SBT6290, a systemically administered Nectin-4-directed TLR8 ImmunoTAC (TM) therapeutic, is a potent human myeloid cell agonist for the treatment of Nectin-4-expressing tumors. (9th November 2020)

Authors:
Metz, Heather; Brender, Ty; Stevens, Brenda; Winship, Damion; Brevik, Jamie; Comeau, Michael; Childs, Monica; Chang, Jenny; Fan, Li-Qun; Xu, Hengyu; Grey, Jonathan; Adamo, Jeffrey; Setter, Ben; Carrillo, Ray; Smith, Sean; Tan, Phil; DuBose, Robert; Latchman, Yvette; Baum, Peter; Odegard, Valerie
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A754
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 712 SBT6290, a systemically administered Nectin-4-directed TLR8 ImmunoTAC (TM) therapeutic, is a potent human myeloid cell agonist for the treatment of Nectin-4-expressing tumors. (9th November 2020)

Authors:
Metz, Heather; Brender, Ty; Stevens, Brenda; Winship, Damion; Brevik, Jamie; Comeau, Michael; Childs, Monica; Chang, Jenny; Fan, Li-Qun; Xu, Hengyu; Grey, Jonathan; Adamo, Jeffrey; Setter, Ben; Carrillo, Ray; Smith, Sean; Tan, Phil; DuBose, Robert; Latchman, Yvette; Baum, Peter; Odegard, Valerie
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A427
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search